Fundraising FoxSameric Bio
1 known investors
Find your way into Sameric Bio
Sign up to see every warm intro you have to Sameric Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sameric Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sameric Bio in-licenses multifunctional protein-based biologics (bispecifics, engagers, degraders, enzyme-linked proteins) from academic researchers and develops them from in-vivo/ex-vivo proof of concept to clinical proof of concept. It combines AI-native protein engineering, systems-pharmacology modeling, and a BSL-2 lab to advance drug candidates in high unmet-need indications.
Founders & leadership
AB
Alexander BelcrediCo-Founder & CEO
LC
Lorenzo CorsiniCo-Founder & CEO
AB
Adriana BadarauCo-Founder & CSO
AP
Albina PoljakCo-Founder & CPO
Investors · 1
Frequently asked questions
- What does Sameric Bio do?
- Sameric Bio in-licenses multifunctional protein-based biologics (bispecifics, engagers, degraders, enzyme-linked proteins) from academic researchers and develops them from in-vivo/ex-vivo proof of concept to clinical proof of concept. It combines AI-native protein engineering, systems-pharmacology modeling, and a BSL-2 lab to advance drug candidates in high unmet-need indications.
- Who are Sameric Bio's investors?
- Sameric Bio's investors include Amino Collective.